Expiratory Muscle Strength Training in Improving Bulbar Function and Quality of Life in Patients With Head and Neck Cancer

Sponsor
Ohio State University Comprehensive Cancer Center (Other)
Overall Status
Completed
CT.gov ID
NCT03175289
Collaborator
(none)
49
1
2
27.1
1.8

Study Details

Study Description

Brief Summary

This randomized clinical trial studies how well expiratory muscle strength training works in improving bulbar function and quality of life in patients with head and neck cancer. Expiratory muscle strength training may help to strengthen the muscles involved in breathing and swallowing and may allow improved breathing, airway safety, swallow function, and quality of life in patients with head and neck cancer.

Condition or Disease Intervention/Treatment Phase
  • Other: Best Practice
  • Other: Educational Intervention
  • Other: Exercise Intervention
  • Other: Expiratory Muscle Strength Training
  • Other: Quality-of-Life Assessment
  • Other: Questionnaire Administration
N/A

Detailed Description

PRIMARY OBJECTIVES:
  1. Investigate the impact of a prophylactic targeted exercise program, expiratory muscle strength training (EMST), on swallowing function and well-being of individuals on head and neck cancer (HNC).

  2. Determine the impact of EMST on objective respiratory measures of individuals with HNC.

  3. Determine the relationship between mean dose across the swallowing muscles (oral tongue and supra-hyoids, base of tongue, superior, middle and inferior pharyngeal constrictors, proximal esophagus)/dose on each muscle and the swallowing functional outcomes from aim 1.

OUTLINE: Patients are randomized to 1 of 2 arms.

ARM I: Patients receive standard of care comprising of written patient education materials focusing on oral care, signs/symptoms of dysphagia/aspiration, and trismus. Patients participate in a therapy session conducted by a speech pathologist over 30 minutes once per week for 6 weeks during chemoradiation therapy. Patients also perform prescribed exercises at home daily for 3 sets of 10 repetitions.

ARM II: Patients receive standard of care comprising of written patient education materials focusing on oral care, signs/symptoms of dysphagia/aspiration, and trismus. Patients participate in a therapy session conducted by a speech pathologist over 30 minutes once per week for 6 weeks during chemoradiation therapy. Patients perform prescribed exercises at home daily for 3 sets of 10 repetitions. Patients also participate in an EMST session over 30 minutes comprising of 5 sets of 5 repetitions daily for 5 days per week for 6 weeks during chemoradiation therapy.

After completion of study, patients are followed up at 1, 3, 6, and 12 months.

Study Design

Study Type:
Interventional
Actual Enrollment :
49 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Supportive Care
Official Title:
The Impact of Expiratory Muscle Strength Training on Bulbar Function and Well Being of Individuals With Head and Neck Cancer
Actual Study Start Date :
Sep 29, 2016
Actual Primary Completion Date :
Jan 3, 2019
Actual Study Completion Date :
Jan 3, 2019

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Arm I (standard of care, home exercises)

Patients receive standard of care comprising of written patient education materials focusing on oral care, signs/symptoms of dysphagia/aspiration, and trismus. Patients participate in a therapy session conducted by a speech pathologist over 30 minutes once per week for 6 weeks during chemoradiation therapy. Patients also perform prescribed exercises at home daily for 3 sets of 10 repetitions.

Other: Best Practice
Undergo therapy session conducted by a speech pathologist
Other Names:
  • standard of care
  • standard therapy
  • Other: Educational Intervention
    Receive standard of care patient education materials focusing on oral care, signs/symptoms of dysphagia/aspiration, and trismus
    Other Names:
  • Education for Intervention
  • Intervention by Education
  • Intervention through Education
  • Intervention, Educational
  • Other: Exercise Intervention
    Perform prescribed home exercises

    Other: Quality-of-Life Assessment
    Ancillary studies
    Other Names:
  • Quality of Life Assessment
  • Other: Questionnaire Administration
    Ancillary studies

    Experimental: Arm II (standard of care, home exercises, EMST)

    Patients receive standard of care comprising of written patient education materials focusing on oral care, signs/symptoms of dysphagia/aspiration, and trismus. Patients participate in a therapy session conducted by a speech pathologist over 30 minutes once per week for 6 weeks during chemoradiation therapy. Patients perform prescribed exercises at home daily for 3 sets of 10 repetitions. Patients also participate in an EMST session over 30 minutes comprising of 5 sets of 5 repetitions daily for 5 days per week for 6 weeks during chemoradiation therapy

    Other: Best Practice
    Undergo therapy session conducted by a speech pathologist
    Other Names:
  • standard of care
  • standard therapy
  • Other: Educational Intervention
    Receive standard of care patient education materials focusing on oral care, signs/symptoms of dysphagia/aspiration, and trismus
    Other Names:
  • Education for Intervention
  • Intervention by Education
  • Intervention through Education
  • Intervention, Educational
  • Other: Exercise Intervention
    Perform prescribed home exercises

    Other: Expiratory Muscle Strength Training
    Participate in EMST
    Other Names:
  • EMST
  • Other: Quality-of-Life Assessment
    Ancillary studies
    Other Names:
  • Quality of Life Assessment
  • Other: Questionnaire Administration
    Ancillary studies

    Outcome Measures

    Primary Outcome Measures

    1. Airway safety during swallowing assessed using the Penetration-Aspiration Scale [Up to 1 year]

      Exploratory mixed effect model will be used to investigate swallow function with time (pre and 1, 3, 6, and 12 month post) as the within-subjects variable and group (expiratory muscle strength training and control) as the between-subjects variable. Pearson or Spearman correlation methods will be used to evaluate the relationship between swallow function/patterning and respiratory and swallow safety measures.

    Secondary Outcome Measures

    1. Eating Assessment Tool-10 [Up to 1 year]

      Collected variables will be estimated through patient and clinician surveys.

    2. Expiratory flow assessed using portable digital peak flow meter [Up to 1 year]

      Exploratory mixed effect model will be used to investigate respiratory measures with time (pre and 1, 3, 6, and 12 month post) as the within-subjects variable and group (expiratory muscle strength training and control) as the between-subjects variable. Pearson or Spearman correlation methods will be used to evaluate the relationship between swallow function/patterning and respiratory and swallow safety measures.

    3. Functional Oral Intake Scale (FOIS) [Up to 1 year]

      Collected variables will be estimated through patient and clinician surveys.

    4. Lingual strength defined as the maximum pressure of the tongue pressing against the hard palate measured using the Iowa Oral Performance Instrument [Up to 1 year]

      Exploratory mixed effect model will be used to investigate swallow function with time (pre and 1, 3, 6, and 12 month post) as the within-subjects variable and group (expiratory muscle strength training and control) as the between-subjects variable. Pearson or Spearman correlation methods will be used to evaluate the relationship between swallow function/patterning and respiratory and swallow safety measures.

    5. Maximum expiratory pressure assessed using the MicroRPM pressure meter [Up to 1 year]

      Exploratory mixed effect model will be used to investigate respiratory measures with time (pre and 1, 3, 6, and 12 month post) as the within-subjects variable and group (expiratory muscle strength training and control) as the between-subjects variable. Pearson or Spearman correlation methods will be used to evaluate the relationship between swallow function/patterning and respiratory and swallow safety measures.

    6. Maximum mandibular opening using the TheraBite range of motion scale [Up to 1 year]

      Exploratory mixed effect model will be used to investigate swallow function with time (pre and 1, 3, 6, and 12 month post) as the within-subjects variable and group (expiratory muscle strength training and control) as the between-subjects variable. Pearson or Spearman correlation methods will be used to evaluate the relationship between swallow function/patterning and respiratory and swallow safety measures.

    7. Patient reported quality of life assessed using European Organization for Research and Treatment of Cancer Quality of Life Questionnaire [Up to 1 year]

      Exploratory mixed effect model will be used to investigate quality of life with time (pre and 1, 3, 6, and 12 month post) as the within-subjects variable and group (expiratory muscle strength training and control) as the between-subjects variable.

    8. Respiratory-swallow phase patterns captured using the standard Modified Barium Swallow Study [Up to 1 year]

      Logistic regression method will be used to explore associations between treatment and respiratory-swallow phase (normal/abnormal).

    9. Swallow pathophysiology assessed using the Modified Barium Swallow Impairment Profile [Up to 1 year]

      Exploratory mixed effect model will be used to investigate swallow function with time (pre and 1, 3, 6, and 12 month post) as the within-subjects variable and group (expiratory muscle strength training and control) as the between-subjects variable. Pearson or Spearman correlation methods will be used to evaluate the relationship between swallow function/patterning and respiratory and swallow safety measures.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    19 Years to 78 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Patients with a definitive, curative treatment plan consisting of chemoradiation for head & neck cancer

    • Surgery, if required, must be limited to: diagnostic biopsy

    Exclusion Criteria:
    • Participants enrolled in a radiation de-intensification protocol

    • Current or previous neurological disease, which may adversely affect swallowing

    • History of oropharyngeal swallowing disorder prior to cancer diagnosis

    • Previous neurosurgery on the brain

    • Severe chronic obstructive pulmonary disease (COPD) requiring oxygen dependence, as this is a contraindication of EMST

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Ohio State University Comprehensive Cancer Center Columbus Ohio United States 43210

    Sponsors and Collaborators

    • Ohio State University Comprehensive Cancer Center

    Investigators

    • Principal Investigator: Loni Arrese, PhD, SLP, Ohio State University Comprehensive Cancer Center

    Study Documents (Full-Text)

    None provided.

    More Information

    Additional Information:

    Publications

    None provided.
    Responsible Party:
    Ohio State University Comprehensive Cancer Center
    ClinicalTrials.gov Identifier:
    NCT03175289
    Other Study ID Numbers:
    • OSU-16023
    • NCI-2017-00848
    First Posted:
    Jun 5, 2017
    Last Update Posted:
    May 21, 2019
    Last Verified:
    May 1, 2019
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of May 21, 2019